News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medivation, Inc. (MDVN) Announces Participation at Upcoming Investor Conference


2/7/2013 9:24:37 AM

SAN FRANCISCO, CA--(Marketwire - February 06, 2013) - Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conference:

  • Patrick Machado, chief business and financial officer, will present at the Leerink Swann Global Healthcare Conference on February 13 at 8:30am ET in New York, NY.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.


Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES